BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33188469)

  • 1. Blood and platelet transfusion from a donor with presymptomatic Covid-19.
    Liapis K; Papoutselis M; Vrachiolias G; Misidou C; Spanoudakis E; Bezirgiannidou Z; Pentidou A; Konstantinidis T; Kotsianidis I
    Ann Hematol; 2021 Aug; 100(8):2133-2134. PubMed ID: 33188469
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components.
    Politis C; Papadaki M; Politi L; Kourti G; Richardson C; Asariotou M; Tsakris A; Mentis A
    Transfus Clin Biol; 2021 Feb; 28(1):55-59. PubMed ID: 33096208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 related callback in blood donors; Outcomes in blood donors and patients.
    Balagholi S; Maghsudlu M; Amini-Kafiabad S; Nazemi AM; Sotoudeh Anvari M
    Transfus Apher Sci; 2021 Aug; 60(4):103129. PubMed ID: 33879420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do I manage long-term blood component shortages in a hospital transfusion service?
    Cohn CS; Pagano MB; Allen ES; Frey KP; Gniadek T; Lokhandwala PM; Murphy CH; Raval JS; Dunbar NM
    Transfusion; 2020 Sep; 60(9):1897-1904. PubMed ID: 32643156
    [No Abstract]   [Full Text] [Related]  

  • 5. Covid 19 vaccination: Latest guidelines on blood donor deferral in India.
    Bhasker B
    Transfus Clin Biol; 2021 Aug; 28(3):299. PubMed ID: 34058381
    [No Abstract]   [Full Text] [Related]  

  • 6. Search for SARS-CoV-2 RNA in platelets from COVID-19 patients.
    Bury L; Camilloni B; Castronari R; Piselli E; Malvestiti M; Borghi M; KuchiBotla H; Falcinelli E; Petito E; Amato F; Paliani U; Vaudo G; Cerotto V; Gori F; Becattini C; De Robertis E; Lazzarini T; Castaldo G; Mencacci A; Gresele P
    Platelets; 2021 Feb; 32(2):284-287. PubMed ID: 33349108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A forecasting model to estimate the drop in blood supplies during the SARS-CoV-2 pandemic in Italy.
    Pati I; Velati C; Mengoli C; Franchini M; Masiello F; Marano G; Veropalumbo E; Vaglio S; Piccinini V; Pupella S; Liumbruno GM
    Transfus Med; 2021 Jun; 31(3):200-205. PubMed ID: 33694217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Donation during COVID-19 Vaccination drive - The Need for Concern.
    Suvvari TK; Kutikuppala LVS; Garikipati NA; Ponnaganti SVK; Kandi VR
    Transfus Clin Biol; 2021 Aug; 28(3):307-308. PubMed ID: 34116916
    [No Abstract]   [Full Text] [Related]  

  • 9. Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood Components.
    Mandel M; Gurevich M; Mandelboim M; Amital H; Achiron A
    Isr Med Assoc J; 2021 Jan; 23(1):7-10. PubMed ID: 33443334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for the presence of SARS-CoV-2 RNA in presymptomatic blood donors.
    Loubaki L; Gantner P; Pagliuzza A; Fausther-Bovendo H; Kobinger G; Chomont N; Germain M
    Transfusion; 2021 Feb; 61(2):649-651. PubMed ID: 33616976
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients.
    Klausen SS; Hervig T; Seghatchian J; Reikvam H
    Transfus Apher Sci; 2014 Oct; 51(2):97-102. PubMed ID: 25242310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
    Pagano MB; Cataife G; Fertrin KY; Gernsheimer T; R Hess J; Staley E; Clark C; Senn N; Tuott E; C Tsang H
    Transfusion; 2020 Dec; 60(12):2859-2866. PubMed ID: 32856307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of transmission of SARS-CoV-2 by platelet transfusion from a COVID-19-positive donor in a hematopoietic stem cell transplantation patient.
    Essa MF; Elbashir E; Batarfi K; Alharbi M
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28658. PubMed ID: 32813297
    [No Abstract]   [Full Text] [Related]  

  • 14. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
    Thiele T; Alt-Mayer T; Greinacher A; Bux J
    Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 transmission and blood transfusion: A case report.
    Cho HJ; Koo JW; Roh SK; Kim YK; Suh JS; Moon JH; Sohn SK; Baek DW
    J Infect Public Health; 2020 Nov; 13(11):1678-1679. PubMed ID: 32405329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of donor self-reporting in securing blood safety during COVID-19 pandemic.
    Ng SC; So CK; Leung JNS; Lau CW; Tsoi WC; Lee CK
    Transfus Med; 2021 Jun; 31(3):213-214. PubMed ID: 33319370
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism.
    Lucijanic M; Krecak I; Soric E; Sedinic M; Sabljic A; Derek L; Jaksic O; Kusec R
    Blood Cancer J; 2021 Nov; 11(11):189. PubMed ID: 34845183
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic.
    Prokopchuk-Gauk O; Petraszko T; Nahirniak S; Doncaster C; Levy I
    Transfusion; 2021 Nov; 61(11):3258-3266. PubMed ID: 34490650
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region.
    Al-Riyami AZ; Abdella YE; Badawi MA; Panchatcharam SM; Ghaleb Y; Maghsudlu M; Satti M; Lahjouji K; Merenkov Z; Adwan A; Feghali R; Gebril N; Hejress S; Hmida S; AlHumaidan H; Jamal D; Najjar O; Raouf M
    Transfus Clin Biol; 2021 Feb; 28(1):16-24. PubMed ID: 33276150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism.
    Shen S; Zhang J; Fang Y; Lu S; Wu J; Zheng X; Deng F
    J Hematol Oncol; 2021 Apr; 14(1):72. PubMed ID: 33926500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.